Ra Medical Systems, Inc. (RMED) |
3.27 0 (0%)
|
01-27 16:00 |
Open: |
3.26 |
Pre. Close: |
3.27 |
High:
|
3.2945 |
Low:
|
3.13 |
Volume:
|
82,104 |
Market Cap:
|
7(M) |
|
|
Technical analysis |
as of: 2023-01-27 4:47:35 PM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 6.61 One year: 8.46 |
Support: |
Support1: 3.08 Support2: 2.57 |
Resistance: |
Resistance1: 5.66 Resistance2: 7.25 |
Pivot: |
3.94  |
Moving Average: |
MA(5): 3.37 MA(20): 4.49 
MA(100): 4.88 MA(250): 11.41  |
MACD: |
MACD(12,26): -0.4 Signal(9): -0.3  |
Stochastic oscillator: |
%K(14,3): 5.8 %D(3): 7  |
RSI: |
RSI(14): 40.2 |
52-week: |
High: 42 Low: 0.28 |
Average Vol(K): |
3-Month: 1,623 (K) 10-Days: 165 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RMED ] has closed above bottom band by 33.5%. Bollinger Bands are 44.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 15 days. This is a sign that the current trend might continue. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
3.3 - 3.32 |
3.32 - 3.33 |
Low:
|
3.09 - 3.11 |
3.11 - 3.13 |
Close:
|
3.24 - 3.27 |
3.27 - 3.3 |
|
Company Description |
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. |
Headline News |
Mon, 23 Jan 2023 2023-01-23 | NYSEAM:RMED | Press Release | Ra Medical ... - Stockhouse
Tue, 17 Jan 2023 Ra Medical Systems Realigns Its Board of Directors - Business Wire
Fri, 13 Jan 2023 Is RA Medical Systems Inc (RMED) Stock a Smart Value Friday? - InvestorsObserver
Thu, 12 Jan 2023 Is RA Medical Systems Inc (RMED) Stock Worth a Buy Thursday? - InvestorsObserver
Tue, 13 Dec 2022 Should You Add RA Medical Systems Inc (RMED) Stock to Your Portfolio Tuesday? - InvestorsObserver
Wed, 07 Dec 2022 RA Medical Systems Inc (RMED) is down 7.21% Wednesday In Premarket Trading - InvestorsObserver
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Neutral |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: AMEX |
Sector: Healthcare |
Industry: Medical Devices |
Shares Out. |
7 (M) |
Shares Float |
7 (M) |
% Held by Insiders
|
2.1 (%) |
% Held by Institutions
|
3 (%) |
Shares Short
|
417 (K) |
Shares Short P.Month
|
477 (K) |
Stock Financials |
EPS
|
-6.66 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
3.05 |
Profit Margin (%)
|
0 |
Operating Margin (%)
|
-766 |
Return on Assets (ttm)
|
-56.6 |
Return on Equity (ttm)
|
-115 |
Qtrly Rev. Growth
|
-92.6 |
Gross Profit (p.s.)
|
-0.16 |
Sales Per Share
|
0.59 |
EBITDA (p.s.)
|
-4.35 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-31 (M) |
Levered Free Cash Flow
|
-18 (M) |
Stock Valuations |
PE Ratio
|
-0.5 |
PEG Ratio
|
0 |
Price to Book value
|
1.06 |
Price to Sales
|
5.52 |
Price to Cash Flow
|
-0.74 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
Your Ad Here
|
|